Get started
Author

Lindsay A. Renfro

Observed name: Renfro, Lindsay A.
OpenAlex ID: A5138420101
Impact of post‐chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children’s Oncology Group AREN0532, AREN0533, and AREN03B2 studies
2026 · Nicholas F. Evageliou, Lindsay A. Renfro, et al. · Cancer · 1
PDF
Impact of Number of Lymph Nodes Sampled and Density of Positive Nodes on Outcomes Among Over 2000 Patients With Stage I to III Favorable Histology Wilms Tumor Enrolled on AREN03B2
2026 · Jennifer H. Aldrink, Lindsay A. Renfro, et al. · Annals of Surgery
Feasibility of Real‐Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials
2026 · Elizabeth A. Mullen, Lindsay A. Renfro, et al. · Pediatric Blood & Cancer
PDF
Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials
2026 · Mallorie B. Heneghan, Lindsay A. Renfro, et al. · Pediatric Blood & Cancer
Patterns of presentation and outcomes in stage IV Hodgkin lymphoma: A report from the Children's Oncology Group ( COG ) AHOD1331 trial
2026 · Dana L. Casey, Lindsay A. Renfro, et al. · British Journal of Haematology
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial
2026 · Xin Tie, Changhee Lee, et al. · Journal of Nuclear Medicine
PDF
Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes
2026 · Aslanyan, Vahan, Nuño, Michelle, et al. · Figshare
Works count: 7
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type